At the Frontline of the Opioid Epidemic, but Unable to Help

July 6, 2017

People seek out the emergency room to get painkillers, but the E.R. remains one of the hardest places to get help for an addiction. (Source: NYT Health)

Read the full article →

Orexo Appeals Zubsolv(R) US District Court Decision

July 6, 2017

UPPSALA, Sweden, Dec 8, 2016 — (Healthcare Sales & Marketing Network) — Orexo AB (publ.) announces that it has appealed the decision rendered by the United States District Court for the District of Delaware on November 15, 2016 regarding the validity of… Biopharmaceuticals, Generics, Litigation Orexo, Zubsolv, buprenorphine, naloxone, Actavis (Source: HSMN NewsFeed)

Read the full article →

Snapshots of an Epidemic: A Look at the Opioid Crisis Across the Country

July 6, 2017

The opioid epidemic killed more than 33,000 people in 2015. What follows are stories of a national affliction that has swept the country, from cities on the West Coast to bedroom communities in the Northeast. (Source: NYT Health) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with […]

Read the full article →

Inside a Killer Drug Epidemic: A Look at America ’ s Opioid Crisis

July 6, 2017

The opioid epidemic killed more than 33,000 people in 2015. What follows are stories of a national affliction that has swept the country, from cities on the West Coast to bedroom communities in the Northeast. (Source: NYT Health)

Read the full article →

Obamacare Repeal Could Cripple Efforts To Combat The Opioid Epidemic

July 6, 2017

WASHINGTON ― Repealing the Affordable Care Act would deal a major blow to efforts to fight addiction in one of the states hardest hit by the opioid epidemic, according to a new study from Harvard Medical School and New York University. Across the country, some four million Americans with addictions or mental health disorders could lose their […]

Read the full article →

Hardly Any Teens Receive Effective Treatment For Opioid Addiction

July 6, 2017

(Reuters Health) – Just a small fraction of adolescents with opioid addiction will receive medications that can help them quit, new research shows. These medications, usually methadone or suboxone, are prescribed to reduce craving for opiates and ease withdrawal symptoms, and studies show they help opiate users to abstain. In 2016, the American Academy of […]

Read the full article →

ARS adding clinics, prescribers to meet opioid treatment demand

July 6, 2017

Accessible Recovery Services, a Pittsburgh-based network of a dozen medically assisted opioid treatment clinics across the state, said it plans to add six more sites and dozens of “extenders” — nurse practitioners and physician assistants able to prescribe drugs like buprenorphine — in the next three to four months to meet demand. Dr. Frank Kunkel, […]

Read the full article →

These Are The 2 Key Ways People Get Hooked On Prescription Opioids

July 6, 2017

This reporting is brought to you by HuffPost’s health and science platform, The Scope. Like us on Facebook and Twitter and tell us your story: [email protected].  — This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may […]

Read the full article →

FDA OKs BioDelivery Sciences ’ Bunavail opioid dependence film

July 6, 2017

BioDelivery Sciences International (NSDQ:BDSI) said today that the FDA approved a supplemental new drug application for its Bunavail buprenorphine and naloxone buccal film. The revised indication allows patients to use the product to initiate buprenorphine treatment for opioid dependence. Induction is the initial process by which a patient transitions from abusing an opioid to buprenorphine […]

Read the full article →

FDA OKs Bunavail for Induction of Opioid Addiction Treatment FDA OKs Bunavail for Induction of Opioid Addiction Treatment

July 6, 2017

The FDA has broadened the indication for Bunavail (buprenorphine and naloxone) buccal film to include induction of buprenorphine treatment for opioid dependence.FDA Approvals (Source: Medscape Psychiatry Headlines)

Read the full article →